Clinical trial
Stalevo in Early Wearing-Off Patients
NCT00125567 · Orion Corporation, Orion Pharma, Industry · Completed
Key facts
| NCT number | NCT00125567 |
|---|---|
| Title | Stalevo in Early Wearing-Off Patients |
| Official title | Multicentre, Randomised, Double-Blind Study to Compare Stalevo to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off |
| Acronym | SEWOP |
| Lead sponsor | Orion Corporation, Orion Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Idiopathic Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Stalevo (levodopa/carbidopa/entacapone), Levodopa/carbidopa |
| Enrollment | 223 |
| Start date | Aug 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Aug 1, 2005 |
| Last update posted | Jun 22, 2009 |
| Countries | Denmark, Finland, Germany, Ireland, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: